Millennium Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
ACA
VCM
HI
Millennium Management's TERN Position: Q1 2026 in Review
Millennium Management increased its Terns Pharmaceuticals (TERN) stake by 205% in Q1 2026, buying an estimated $83.1M and bringing the position to 3,011,558 shares worth $159M. The position accounts for 0.07% of the portfolio, ranked #279.
Millennium Management first reported a position in TERN in Q2 2021 and has held it in 19 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.
- Millennium Management held 3,011,558 shares of Terns Pharmaceuticals worth $159M as of Q1 2026.
- Millennium Management bought 2,024,252 Terns Pharmaceuticals shares in Q1 2026, an estimated $83.1M.
- Terns Pharmaceuticals made up 0.07% of Millennium Management's portfolio in Q1 2026, its #279 holding.
- Millennium Management first reported a position in Terns Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
- 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.